Altria Group, Inc. (MO) Is a Trending Stock: Facts to Know Before Betting on It — Positive

MO   Zacks Investment Research — January 22, 2026

Altria (MO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

image for news Altria Group, Inc. (MO) Is a Trending Stock: Facts to Know Before Betting on It

Investors Heavily Search First Solar, Inc. (FSLR): Here is What You Need to Know — Positive

FSLR   Zacks Investment Research — January 22, 2026

Recently, Zacks.com users have been paying close attention to First Solar (FSLR). This makes it worthwhile to examine what the stock has in store.

image for news Investors Heavily Search First Solar, Inc. (FSLR): Here is What You Need to Know

Is Most-Watched Stock Abercrombie & Fitch Company (ANF) Worth Betting on Now? — Positive

ANF   Zacks Investment Research — January 22, 2026

Recently, Zacks.com users have been paying close attention to Abercrombie (ANF). This makes it worthwhile to examine what the stock has in store.

image for news Is Most-Watched Stock Abercrombie & Fitch Company (ANF) Worth Betting on Now?

The Progressive Corporation (PGR) is Attracting Investor Attention: Here is What You Should Know — Positive

PGR   Zacks Investment Research — January 22, 2026

Recently, Zacks.com users have been paying close attention to Progressive (PGR). This makes it worthwhile to examine what the stock has in store.

image for news The Progressive Corporation (PGR) is Attracting Investor Attention: Here is What You Should Know

3 Cannabis REITs Investors Are Watching Closely in January 2026 — Neutral

IIPR  NLCP  REFI   MarijuanaStocks — January 22, 2026

The cannabis sector continues evolving as capital markets slowly reopen. However, volatility remains high for plant-touching cannabis operators. Because of that, many investors look toward cannabis real estate investment trusts. These companies earn income through rent or interest, not cannabis sales. As a result, revenue can be more predictable during uncertain periods. Still, not all cannabis REITs follow the same strategy. Some focus on property ownership, while others specialize in lending. Therefore, understanding each model is essential before investing. January 2026 is an important month as investors reassess income opportunities. Below are three cannabis REITs investors are actively watching this …

image for news 3 Cannabis REITs Investors Are Watching Closely in January 2026

Wells Fargo & Company (WFC) is Attracting Investor Attention: Here is What You Should Know — Positive

WFC   Zacks Investment Research — January 22, 2026

Wells Fargo (WFC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

image for news Wells Fargo & Company (WFC) is Attracting Investor Attention: Here is What You Should Know

Investors Heavily Search Marvell Technology, Inc. (MRVL): Here is What You Need to Know — Positive

MRVL   Zacks Investment Research — January 22, 2026

Marvell (MRVL) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

image for news Investors Heavily Search Marvell Technology, Inc. (MRVL): Here is What You Need to Know

Netflix has agreed to pay $27.75 per share for Warner Bros. Discovery's movie studio and streaming business, but not the cable networks, which own WBD's sports rights.

image for news Paramount is betting European regulators won't approve WBD-Netflix. Here's how it could play out

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA ("ADC Therapeutics" or the "Company") (NYSE: ADCT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Apogee Enterprises, Inc. ("Apogee" or the "Company") (NASDAQ: APOG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Apogee Enterprises, Inc. - APOG

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (NASDAQ: VNDA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vanda Pharmaceuticals Inc. - VNDA

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of First Solar, Inc. ("First Solar" or the "Company") (NASDAQ: FSLR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of First Solar, Inc. - FSLR

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Trip.com Group Limited ("Trip.com" or the "Company") (NASDAQ: TCOM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Trip.com Group Limited - TCOM

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Atara Biotherapeutics, Inc. ("Atara" or the "Company") (NASDAQ: ATRA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Bath & Body Works, Inc. ("Bath & Body Works" or the "Company") (NYSE: BBWI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Bath & Body Works, Inc. of Class Action Lawsuit and Upcoming Deadlines - BBWI

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Teleflex Incorporated ("Teleflex" or the "Company") (NYSE: TFX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sigma Lithium Corporation ("Sigma Lithium" or the "Company") (NASDAQ: SGML). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sigma Lithium Corporation - SGML

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Aquestive Therapeutics, Inc. ("Aquestive" or the "Company") (NASDAQ: AQST). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aquestive Therapeutics, Inc. - AQST

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AST SpaceMobile, Inc. ("AST" or the "Company") (NASDAQ: ASTS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AST SpaceMobile, Inc. - ASTS

NEW YORK, Jan. 22, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against F5, Inc. ("F5" or the "Company") (NASDAQ: FFIV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

image for news INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in F5, Inc. of Class Action Lawsuit and Upcoming Deadlines - FFIV